Your Source for Venture Capital and Private Equity Financings

VC-funded Company:

Loxo Oncology
c/o Aisling Capital
888 Seventh Avenue, 30th Floor
New York, NY 10106
Phone: 212-651-6380
https://www.loxooncology.com/

Loxo Oncology was incorporated in Delaware in May 2013 and was founded by Josh Bilenker, M.D., a partner at Aisling Capital. Loxo Oncology is committed to bringing targeted cancer therapies rapidly into the clinic that have an opportunity for outsized clinical effects in genetically defined patient populations. Loxo Oncology derives its company name from an attendant of the Greek goddess Artemis, who represented the concept of trajectory in the sport of archery.

Key Contact
Name
Josh Bilenker
Title
CEO
E-Mail
Funding Events

Date
Amount
Type
Investors
Valuation
10/03/13 $33,000,000 Series A Aisling Capital
OrbiMed Advisors
undisclosed
05/07/14 $24,000,000 Series B Aisling Capital
OrbiMed Advisors
undisclosed